Journal of Diabetes Science and Technology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Diabetic Wound Imaging Using a Noncontact Near-Infrared Scanner: A Pilot Study
(Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Godavarty, A., Rao, P. N. S., Khandavilli, Y., Jung, Y.-J. Tags: Letters to the Editor Source Type: research

Patient Self-Management of Diabetes Care in the Inpatient Setting: Con
We report the case of a patient admitted to the surgical service who was self-administering his home insulin, often without telling his nurse or physician. He was aiming for tight glycemic control, which resulted in life-threatening hypoglycemia. While patients can often self-manage their diabetes in the outpatient setting, inpatient management of diabetes is very different. Patients may not be familiar with common scenarios requiring adjustments of insulin therapy. Therefore, we recommend against self-management of diabetes in the hospital. However, the patients should be involved in discussions about management of their ...
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Shah, A. D., Rushakoff, R. J. Tags: Commentaries Source Type: research

Patient Self-Management of Diabetes Care in the Inpatient Setting: Pro
Patients should be allowed to manage their diabetes in the hospital. Diabetes mellitus is a common and sometimes difficult to control medical issue in hospitalized patients. Oftentimes patients who have been controlling their diabetes well as an outpatient are not allowed to continue this management on the inpatient setting, which can lead to hypo- and hyperglycemia. Involving the patient in his or her diabetes care, including self-management in select patients, may provide a safe and effective way of improving glycemic control and patient satisfaction. This may particularly benefit the dosing and coordination of meal-time...
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Mabrey, M. E., Setji, T. L. Tags: Commentaries Source Type: research

Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions
This article proposes a composite metric, the hypoglycemia-A1c score (HAS), as the basis for a more comprehensive approach for the stakeholders in diabetes treatment to better understand how an intervention affects diabetes management. The article also demonstrates how additional parameters such as effects on weight, quality of life, and costs could be included in such a scoring system. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Vigersky, R. A. Tags: Commentaries Source Type: research

Cybersecurity for Connected Diabetes Devices
Diabetes devices are increasingly connected wirelessly to each other and to data-displaying reader devices. Threats to the accurate flow of information and commands may compromise the function of these devices and put their users at risk of health complications. Sound cybersecurity of connected diabetes devices is necessary to maintain confidentiality, integrity, and availability of the data and commands. Diabetes devices can be hacked by unauthorized agents and also by patients themselves to extract data that are not automatically provided by product software. Unauthorized access to connected diabetes devices has been sim...
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Klonoff, D. C. Tags: Commentaries Source Type: research

Safe and Efficacious Use of Automated Bolus Advisors in Individuals Treated With Multiple Daily Insulin Injection (MDI) Therapy: Lessons Learned From the Automated Bolus Advisor Control and Usability Study (ABACUS)
Numerous studies have shown that use of integrated automated bolus advisors (BAs) provides significant benefits to individuals using insulin pump devices, including improved glycemic control and greater treatment satisfaction. Within the past few years, BA devices have been developed specifically for individuals treated with multiple daily insulin injection (MDI) therapy; however, many clinicians who treat these individuals may be unfamiliar with insulin pump therapy and, thus, BA use. Findings from the Automated Bolus Advisor Control and Usability Study (ABACUS) revealed that BA use can be efficacious and clinically meani...
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Parkin, C. G., Barnard, K., Hinnen, D. A. Tags: Clinical Applications of Diabetes Technology Source Type: research

Hypo- and Hyperglycemic Alarms: Devices and Algorithms
This article reviews devices to warn individuals of impending hypo- and hyperglycemia; biosignals used by these devices include electroencephalography, electrocardiography, skin galvanic resistance, diabetes alert dogs, and continuous glucose monitors (CGMs). While systems based on other technology are increasing in performance and decreasing in size, CGM technology remains the best method for both reactive and predictive alarming of hypo- or hyperglycemia. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Howsmon, D., Bequette, B. W. Tags: Review Articles Source Type: research

Big Data Technologies: New Opportunities for Diabetes Management
This article reviews the main concepts and definitions related to big data, it presents some efforts in health care, and discusses the potential role of big data in diabetes care. Finally, as an example, it describes the research efforts carried on in the MOSAIC project, funded by the European Commission. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Bellazzi, R., Dagliati, A., Sacchi, L., Segagni, D. Tags: Review Articles Source Type: research

Where to Go Now With V-Go?
V-Go™ is a mechanical continuous insulin delivery device releasing a basal amount of rapid acting insulin that also allows the user the ability to deliver discrete meal time or correction doses. This analysis reviews available published literature on the technology, and discusses a recent article comparing the V-Go system with multiple daily insulin injection therapy. Finally, suggestions for future studies are provided. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Thompson, B. M., Cook, C. B. Tags: Original Articles Source Type: research

V-Go Insulin Delivery System Versus Multiple Daily Insulin Injections for Patients With Uncontrolled Type 2 Diabetes Mellitus
Type 2 diabetes mellitus affects over 29.1 million Americans, diagnosed and undiagnosed. Achieving and maintaining glycemic control for these patients is of extreme importance when working to prevent complications and improve quality of life for patients. The V-Go is a newly developed insulin delivery system. The push of a button inserts a needle into the patient once daily and remains attached for 24 hours. The V-Go is designed to release a set basal rate throughout the day, while allowing patients to provide up to 36 units of on-demand bolus insulin with the manual click of 2 buttons. It is a spring-loaded device filled ...
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Winter, A., Lintner, M., Knezevich, E. Tags: Original Articles Source Type: research

Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 Subjects
Conclusions: This survey shows interesting differences in real-world use of insulin pumps in 2 large markets, and suggests areas where insulin pumps and CGMs might be improved. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Walsh, J., Roberts, R., Weber, D., Faber-Heinemann, G., Heinemann, L. Tags: Original Articles Source Type: research

Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study
Conclusions: Results indicated that the accuracy of CGM algorithms might potentially affect the precision of the CGM-based insulin adjustments for type 1 diabetes patients. However, a larger study with several clinical centers, with higher number of clinicians and patients is required to validate the impact of CGM accuracy on decisions precision. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Mahmoudi, Z., Johansen, M. D., Norgaard, H. H., Andersen, S., Pedersen-Bjergaard, U., Tarnow, L., Christiansen, J. S., Hejlesen, O. Tags: Original Articles Source Type: research

The Effects of a Mobile Phone Application on Quality of Life in Patients With Type 1 Diabetes Mellitus: A Randomized Controlled Trial
Conclusions: The use of the DBEES application in the management of patients with T1DM for 3 months yields no alterations in quality of life compared to the standard paper diary. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Drion, I., Pameijer, L. R., van Dijk, P. R., Groenier, K. H., Kleefstra, N., Bilo, H. J. G. Tags: Original Articles Source Type: research

Youth-Perceived Burden of Type 1 Diabetes: Problem Areas in Diabetes Survey-Pediatric Version (PAID-Peds)
Conclusions: This new measure, the PAID-Peds, of youth-reported burden related to type 1 diabetes may have clinical and research utility, particularly in the current era of emerging diabetes technologies that require ongoing patient input. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Markowitz, J. T., Volkening, L. K., Butler, D. A., Laffel, L. M. B. Tags: Original Articles Source Type: research

Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naive Patients With Type 2 Diabetes
Conclusions: The dulaglutide single-dose pen was found to be a safe and effective device for use by patients with T2D who were injection-naïve. A positive injection experience is an important factor for patients and providers when initiating injectable therapy. (Source: Journal of Diabetes Science and Technology)
Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Matfin, G., Van Brunt, K., Zimmermann, A. G., Threlkeld, R., Ignaut, D. A. Tags: Original Articles Source Type: research